RIGL · Rigel Pharmaceuticals Inc · Share Buybacks
$47.15
+0.18 (+0.38%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$900.00M
Shares
18.68M
Volume · Oct 2
185.94K
Avg daily vol (3M)
307.4K
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2020-08-04 | 2024-08-02 | $100,000,000 | — | — | 10-Q , filed 2026-08-04 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Quarter Ended | Cash Spent | Source |
|---|---|---|
| 2026-06-30 | $511,000 Δ | 10-Q, filed 2026-08-04 |
| 2026-03-31 | $3,740,000 | 10-Q, filed 2026-05-05 |
| 2025-06-30 | $0 Δ | 10-Q, filed 2026-08-04 |
| 2025-03-31 | $0 | 10-Q, filed 2026-05-05 |